InvestorsHub Logo
Followers 16
Posts 983
Boards Moderated 0
Alias Born 09/27/2013

Re: Starbase9 post# 6461

Wednesday, 03/26/2014 4:32:46 AM

Wednesday, March 26, 2014 4:32:46 AM

Post# of 106840
Marvel was the Myocell trials being delivered via the J&J MyoStar. Marvel was at phase 2/3

Mirror is the same Myocell trial only this time being delivered via the BioHeart MyoCath. Mirror the the phase 3 of Marvel... (Someone correct me if I'm wrong)

REGEN is Myocell SDF-1. It was never started because it isn't intended to yet. Approval for trials was attained but it is a gene modified version of Myocell. In other words, second generation (new and improved). Those trials will probably commence IMO after full enrollment, full funding, and completion of Mirror phase 3.

BioHearts main focus right now is the Mirror trial using BioHearts own developed catheter, MyoCath. Once they can get full enrollment their task is to get Mirror phase 3 to compliment Marvel Phase 2/3 results. Hence the name "Mirror" (again, someone correct me if I'm wrong)